660 related articles for article (PubMed ID: 16258992)
1. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
[TBL] [Abstract][Full Text] [Related]
2. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs 1. Simultaneous determination of quinidine and permeability markers in rat in situ perfusion samples.
Varma MV; Sarkar M; Kapoor N; Panchagnula R
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):243-9. PubMed ID: 15664356
[TBL] [Abstract][Full Text] [Related]
3. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
[TBL] [Abstract][Full Text] [Related]
4. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
5. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
[TBL] [Abstract][Full Text] [Related]
6. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
7. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
8. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
9. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
10. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.
Okyar A; Dressler C; Hanafy A; Baktir G; Lemmer B; Spahn-Langguth H
Chronobiol Int; 2012 May; 29(4):443-53. PubMed ID: 22489638
[TBL] [Abstract][Full Text] [Related]
11. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
12. Study on absorption sites of quinidine and methotrexate in rat intestine.
Murakami T; Yokooji T; Mori N
Pharmazie; 2010 Jun; 65(6):440-7. PubMed ID: 20614693
[TBL] [Abstract][Full Text] [Related]
13. Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.
Igel S; Drescher S; Mürdter T; Hofmann U; Heinkele G; Tegude H; Glaeser H; Brenner SS; Somogyi AA; Omari T; Schäfer C; Eichelbaum M; Fromm MF
Clin Pharmacokinet; 2007; 46(9):777-85. PubMed ID: 17713975
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
15. The complexity of intestinal absorption and exsorption of digoxin in rats.
Yao HM; Chiou WL
Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832
[TBL] [Abstract][Full Text] [Related]
16. Characterization of intestinal absorption of quinidine, a P-glycoprotein substrate, given as a powder in rats.
Mori N; Iwamoto H; Yokooji T; Murakami T
Pharmazie; 2012 May; 67(5):384-8. PubMed ID: 22764568
[TBL] [Abstract][Full Text] [Related]
17. The Consequence of Drug-Drug Interactions Influencing the Interplay between P-Glycoprotein and Cytochrome P450 3a: An Ex Vivo Study with Rat Precision-Cut Intestinal Slices.
Li M; de Graaf IA; Siissalo S; de Jager MH; van Dam A; Groothuis GM
Drug Metab Dispos; 2016 May; 44(5):683-91. PubMed ID: 26932816
[TBL] [Abstract][Full Text] [Related]
18. Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine.
Emi Y; Tsunashima D; Ogawara K; Higaki K; Kimura T
J Pharm Sci; 1998 Mar; 87(3):295-9. PubMed ID: 9523981
[TBL] [Abstract][Full Text] [Related]
19. Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats.
Neerati P; Ganji D; Bedada SK
Eur J Pharm Sci; 2011 Sep; 44(1-2):27-31. PubMed ID: 21640186
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
